HP Tech Ventures Healthcare

HP Tech Ventures Healthcare represents the healthcare-focused activity of HP’s corporate venture organization, deploying capital into early-stage healthtech, advanced 3D printing applications in medtech, and digital clinical platforms. The thesis tracks HP’s commercial footprint: print and 3D printing capability, computing platforms, and enterprise software workflows that intersect with clinical environments. Investment categories sit within digital health and health IT, with particular attention to areas where HP’s hardware or software capabilities can meaningfully accelerate a portfolio company. Limited public information is available on a healthcare-specific partner roster and detailed portfolio composition in standard venture format, consistent with healthcare being a vertical inside a broader corporate venture organization.

The fund participates at Series A and Series B with check sizes of $1M to $5M, positioning HP Tech Ventures Healthcare as a meaningful institutional co-investor with strategic optionality. The Palo Alto base situates the fund inside the core US healthtech ecosystem, and geographic scope follows the broader corporate posture, US-anchored with selective international exposure where strategic alignment exists. The fund’s strategic value is most apparent for companies whose roadmap intersects with 3D printing, enterprise IT, or clinical workflow integration.

For founders, HP Tech Ventures Healthcare is best engaged when there is a credible alignment between the company’s technology and HP’s commercial capabilities, whether through 3D printing for medical devices, enterprise health IT, or computing platforms supporting clinical software. Diligence weighs both standalone investment merit and the strategic fit. Founders pursuing biopharma development, services-led care delivery without a software dimension, or consumer health products without an enterprise or hardware angle will find the strategic case harder to make. The right fit is a company that benefits from a partnership with HP, not just from its capital.